Decibel Cannabis Company Inc.
Decibel Cannabis Company Inc. (DBCCF) Stock Competitors & Peer Comparison
See (DBCCF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| DBCCF | $0.09 | +5.30% | 52.2M | 4.53 | $0.02 | N/A |
| IPSEY | $42.73 | -13.59% | 56.5B | 27.93 | $1.53 | +0.93% |
| MKGAF | $128.05 | +2.84% | 55.5B | 16.37 | $7.80 | +1.96% |
| TKPHF | $34.05 | +0.00% | 53.8B | 77.39 | $0.44 | +3.88% |
| MKKGY | $24.65 | +3.05% | 53.2B | 15.69 | $1.56 | +2.05% |
| HLNCF | $5.03 | +4.57% | 43.1B | 19.38 | $0.25 | +1.89% |
| SDZNY | $76.62 | +0.90% | 33.5B | 37.10 | $2.09 | +0.94% |
| TEVJF | $28.36 | +0.00% | 32.5B | 23.44 | $1.21 | N/A |
| SGIOY | $10.67 | +1.92% | 18.3B | 17.11 | $0.63 | +1.87% |
| SGIOF | $21.45 | +0.00% | 18.3B | 17.02 | $1.26 | +2.06% |
Stock Comparison
DBCCF vs IPSEY Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, IPSEY has a market cap of 56.5B. Regarding current trading prices, DBCCF is priced at $0.09, while IPSEY trades at $42.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas IPSEY's P/E ratio is 27.93. In terms of profitability, DBCCF's ROE is +0.13%, compared to IPSEY's ROE of +0.10%. Regarding short-term risk, DBCCF is more volatile compared to IPSEY. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check IPSEY's competition here
DBCCF vs MKGAF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, MKGAF has a market cap of 55.5B. Regarding current trading prices, DBCCF is priced at $0.09, while MKGAF trades at $128.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas MKGAF's P/E ratio is 16.37. In terms of profitability, DBCCF's ROE is +0.13%, compared to MKGAF's ROE of +0.09%. Regarding short-term risk, DBCCF is more volatile compared to MKGAF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check MKGAF's competition here
DBCCF vs TKPHF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, TKPHF has a market cap of 53.8B. Regarding current trading prices, DBCCF is priced at $0.09, while TKPHF trades at $34.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas TKPHF's P/E ratio is 77.39. In terms of profitability, DBCCF's ROE is +0.13%, compared to TKPHF's ROE of +0.02%. Regarding short-term risk, DBCCF is more volatile compared to TKPHF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check TKPHF's competition here
DBCCF vs MKKGY Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, MKKGY has a market cap of 53.2B. Regarding current trading prices, DBCCF is priced at $0.09, while MKKGY trades at $24.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas MKKGY's P/E ratio is 15.69. In terms of profitability, DBCCF's ROE is +0.13%, compared to MKKGY's ROE of +0.09%. Regarding short-term risk, DBCCF is more volatile compared to MKKGY. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check MKKGY's competition here
DBCCF vs HLNCF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, HLNCF has a market cap of 43.1B. Regarding current trading prices, DBCCF is priced at $0.09, while HLNCF trades at $5.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas HLNCF's P/E ratio is 19.38. In terms of profitability, DBCCF's ROE is +0.13%, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, DBCCF is more volatile compared to HLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check HLNCF's competition here
DBCCF vs SDZNY Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, SDZNY has a market cap of 33.5B. Regarding current trading prices, DBCCF is priced at $0.09, while SDZNY trades at $76.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas SDZNY's P/E ratio is 37.10. In terms of profitability, DBCCF's ROE is +0.13%, compared to SDZNY's ROE of +0.08%. Regarding short-term risk, DBCCF is more volatile compared to SDZNY. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check SDZNY's competition here
DBCCF vs TEVJF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, TEVJF has a market cap of 32.5B. Regarding current trading prices, DBCCF is priced at $0.09, while TEVJF trades at $28.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas TEVJF's P/E ratio is 23.44. In terms of profitability, DBCCF's ROE is +0.13%, compared to TEVJF's ROE of +0.20%. Regarding short-term risk, DBCCF is more volatile compared to TEVJF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check TEVJF's competition here
DBCCF vs SGIOY Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, SGIOY has a market cap of 18.3B. Regarding current trading prices, DBCCF is priced at $0.09, while SGIOY trades at $10.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas SGIOY's P/E ratio is 17.11. In terms of profitability, DBCCF's ROE is +0.13%, compared to SGIOY's ROE of +0.14%. Regarding short-term risk, DBCCF is more volatile compared to SGIOY. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check SGIOY's competition here
DBCCF vs SGIOF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, SGIOF has a market cap of 18.3B. Regarding current trading prices, DBCCF is priced at $0.09, while SGIOF trades at $21.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas SGIOF's P/E ratio is 17.02. In terms of profitability, DBCCF's ROE is +0.13%, compared to SGIOF's ROE of +0.14%. Regarding short-term risk, DBCCF is more volatile compared to SGIOF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check SGIOF's competition here
DBCCF vs TAIPY Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, TAIPY has a market cap of 18.1B. Regarding current trading prices, DBCCF is priced at $0.09, while TAIPY trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas TAIPY's P/E ratio is 82.35. In terms of profitability, DBCCF's ROE is +0.13%, compared to TAIPY's ROE of +0.02%. Regarding short-term risk, DBCCF is more volatile compared to TAIPY. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check TAIPY's competition here
DBCCF vs ESALY Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, DBCCF is priced at $0.09, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas ESALY's P/E ratio is 20.54. In terms of profitability, DBCCF's ROE is +0.13%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, DBCCF is more volatile compared to ESALY. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check ESALY's competition here
DBCCF vs BIOVF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, BIOVF has a market cap of 14.3B. Regarding current trading prices, DBCCF is priced at $0.09, while BIOVF trades at $41.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas BIOVF's P/E ratio is 295.14. In terms of profitability, DBCCF's ROE is +0.13%, compared to BIOVF's ROE of +0.01%. Regarding short-term risk, DBCCF is more volatile compared to BIOVF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check BIOVF's competition here
DBCCF vs IPSEF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, IPSEF has a market cap of 9.4B. Regarding current trading prices, DBCCF is priced at $0.09, while IPSEF trades at $113.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas IPSEF's P/E ratio is 18.07. In terms of profitability, DBCCF's ROE is +0.13%, compared to IPSEF's ROE of +0.12%. Regarding short-term risk, DBCCF is more volatile compared to IPSEF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check IPSEF's competition here
DBCCF vs ESAIY Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, ESAIY has a market cap of 8.7B. Regarding current trading prices, DBCCF is priced at $0.09, while ESAIY trades at $7.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas ESAIY's P/E ratio is 27.23. In terms of profitability, DBCCF's ROE is +0.13%, compared to ESAIY's ROE of +0.05%. Regarding short-term risk, DBCCF is more volatile compared to ESAIY. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check ESAIY's competition here
DBCCF vs ESALF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, ESALF has a market cap of 8.6B. Regarding current trading prices, DBCCF is priced at $0.09, while ESALF trades at $29.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas ESALF's P/E ratio is 27.82. In terms of profitability, DBCCF's ROE is +0.13%, compared to ESALF's ROE of +0.05%. Regarding short-term risk, DBCCF is more volatile compared to ESALF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check ESALF's competition here
DBCCF vs SFOSF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, SFOSF has a market cap of 7.2B. Regarding current trading prices, DBCCF is priced at $0.09, while SFOSF trades at $2.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas SFOSF's P/E ratio is 15.06. In terms of profitability, DBCCF's ROE is +0.13%, compared to SFOSF's ROE of +0.07%. Regarding short-term risk, DBCCF is more volatile compared to SFOSF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check SFOSF's competition here
DBCCF vs LVZPF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, LVZPF has a market cap of 6.1B. Regarding current trading prices, DBCCF is priced at $0.09, while LVZPF trades at $5.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas LVZPF's P/E ratio is 15.35. In terms of profitability, DBCCF's ROE is +0.13%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, DBCCF is more volatile compared to LVZPF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check LVZPF's competition here
DBCCF vs GZPHF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, GZPHF has a market cap of 5.9B. Regarding current trading prices, DBCCF is priced at $0.09, while GZPHF trades at $2.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas GZPHF's P/E ratio is 9.00. In terms of profitability, DBCCF's ROE is +0.13%, compared to GZPHF's ROE of +0.08%. Regarding short-term risk, DBCCF is more volatile compared to GZPHF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check GZPHF's competition here
DBCCF vs DNPUF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, DNPUF has a market cap of 5.2B. Regarding current trading prices, DBCCF is priced at $0.09, while DNPUF trades at $13.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas DNPUF's P/E ratio is 5.32. In terms of profitability, DBCCF's ROE is +0.13%, compared to DNPUF's ROE of +0.49%. Regarding short-term risk, DBCCF is more volatile compared to DNPUF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check DNPUF's competition here
DBCCF vs SMDPY Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, SMDPY has a market cap of 4.8B. Regarding current trading prices, DBCCF is priced at $0.09, while SMDPY trades at $12.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas SMDPY's P/E ratio is 4.95. In terms of profitability, DBCCF's ROE is +0.13%, compared to SMDPY's ROE of +0.49%. Regarding short-term risk, DBCCF is more volatile compared to SMDPY. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check SMDPY's competition here
DBCCF vs HLUBF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, HLUBF has a market cap of 4.8B. Regarding current trading prices, DBCCF is priced at $0.09, while HLUBF trades at $4.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas HLUBF's P/E ratio is 9.84. In terms of profitability, DBCCF's ROE is +0.13%, compared to HLUBF's ROE of +0.13%. Regarding short-term risk, DBCCF is more volatile compared to HLUBF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check HLUBF's competition here
DBCCF vs HLBBF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, HLBBF has a market cap of 4.5B. Regarding current trading prices, DBCCF is priced at $0.09, while HLBBF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas HLBBF's P/E ratio is 11.18. In terms of profitability, DBCCF's ROE is +0.13%, compared to HLBBF's ROE of +0.13%. Regarding short-term risk, DBCCF is more volatile compared to HLBBF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check HLBBF's competition here
DBCCF vs SGFEF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, SGFEF has a market cap of 4.4B. Regarding current trading prices, DBCCF is priced at $0.09, while SGFEF trades at $100.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas SGFEF's P/E ratio is 20.66. In terms of profitability, DBCCF's ROE is +0.13%, compared to SGFEF's ROE of +0.16%. Regarding short-term risk, DBCCF is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for DBCCF.Check SGFEF's competition here
DBCCF vs HKMPF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, HKMPF has a market cap of 3.8B. Regarding current trading prices, DBCCF is priced at $0.09, while HKMPF trades at $17.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas HKMPF's P/E ratio is 9.56. In terms of profitability, DBCCF's ROE is +0.13%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, DBCCF is more volatile compared to HKMPF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check HKMPF's competition here
DBCCF vs HKMPY Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, HKMPY has a market cap of 3.7B. Regarding current trading prices, DBCCF is priced at $0.09, while HKMPY trades at $33.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas HKMPY's P/E ratio is 9.39. In terms of profitability, DBCCF's ROE is +0.13%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, DBCCF is more volatile compared to HKMPY. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check HKMPY's competition here
DBCCF vs APNHF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, APNHF has a market cap of 3.6B. Regarding current trading prices, DBCCF is priced at $0.09, while APNHF trades at $8.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas APNHF's P/E ratio is -34.17. In terms of profitability, DBCCF's ROE is +0.13%, compared to APNHF's ROE of -0.02%. Regarding short-term risk, DBCCF is more volatile compared to APNHF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check APNHF's competition here
DBCCF vs ULIHF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, ULIHF has a market cap of 3.4B. Regarding current trading prices, DBCCF is priced at $0.09, while ULIHF trades at $1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas ULIHF's P/E ratio is 7.08. In terms of profitability, DBCCF's ROE is +0.13%, compared to ULIHF's ROE of +0.13%. Regarding short-term risk, DBCCF is more volatile compared to ULIHF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check ULIHF's competition here
DBCCF vs APNHY Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, APNHY has a market cap of 3.3B. Regarding current trading prices, DBCCF is priced at $0.09, while APNHY trades at $7.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas APNHY's P/E ratio is -31.17. In terms of profitability, DBCCF's ROE is +0.13%, compared to APNHY's ROE of -0.02%. Regarding short-term risk, DBCCF is more volatile compared to APNHY. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check APNHY's competition here
DBCCF vs LBTSF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, LBTSF has a market cap of 3.3B. Regarding current trading prices, DBCCF is priced at $0.09, while LBTSF trades at $15.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas LBTSF's P/E ratio is 61.40. In terms of profitability, DBCCF's ROE is +0.13%, compared to LBTSF's ROE of +0.04%. Regarding short-term risk, DBCCF is more volatile compared to LBTSF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check LBTSF's competition here
DBCCF vs CHSYF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, CHSYF has a market cap of 3.3B. Regarding current trading prices, DBCCF is priced at $0.09, while CHSYF trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas CHSYF's P/E ratio is 13.50. In terms of profitability, DBCCF's ROE is +0.13%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, DBCCF is less volatile compared to CHSYF. This indicates potentially lower risk in terms of short-term price fluctuations for DBCCF.Check CHSYF's competition here
DBCCF vs HYPMY Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, HYPMY has a market cap of 3.2B. Regarding current trading prices, DBCCF is priced at $0.09, while HYPMY trades at $4.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas HYPMY's P/E ratio is 12.53. In terms of profitability, DBCCF's ROE is +0.13%, compared to HYPMY's ROE of +0.10%. Regarding short-term risk, DBCCF is more volatile compared to HYPMY. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check HYPMY's competition here
DBCCF vs INVVY Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, DBCCF is priced at $0.09, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas INVVY's P/E ratio is -62.42. In terms of profitability, DBCCF's ROE is +0.13%, compared to INVVY's ROE of -0.99%. Regarding short-term risk, DBCCF is more volatile compared to INVVY. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check INVVY's competition here
DBCCF vs IZQVF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, DBCCF is priced at $0.09, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, DBCCF's ROE is +0.13%, compared to IZQVF's ROE of -0.99%. Regarding short-term risk, DBCCF is more volatile compared to IZQVF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check IZQVF's competition here
DBCCF vs HMDCF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, HMDCF has a market cap of 2.4B. Regarding current trading prices, DBCCF is priced at $0.09, while HMDCF trades at $2.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas HMDCF's P/E ratio is 5.32. In terms of profitability, DBCCF's ROE is +0.13%, compared to HMDCF's ROE of +0.42%. Regarding short-term risk, DBCCF is less volatile compared to HMDCF. This indicates potentially lower risk in terms of short-term price fluctuations for DBCCF.Check HMDCF's competition here
DBCCF vs NPPNY Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, NPPNY has a market cap of 2.3B. Regarding current trading prices, DBCCF is priced at $0.09, while NPPNY trades at $8.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas NPPNY's P/E ratio is 10.77. In terms of profitability, DBCCF's ROE is +0.13%, compared to NPPNY's ROE of +0.12%. Regarding short-term risk, DBCCF is more volatile compared to NPPNY. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check NPPNY's competition here
DBCCF vs NPNKF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, NPNKF has a market cap of 2.2B. Regarding current trading prices, DBCCF is priced at $0.09, while NPNKF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas NPNKF's P/E ratio is 10.74. In terms of profitability, DBCCF's ROE is +0.13%, compared to NPNKF's ROE of +0.11%. Regarding short-term risk, DBCCF is more volatile compared to NPNKF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check NPNKF's competition here
DBCCF vs DMPHF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, DBCCF is priced at $0.09, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas DMPHF's P/E ratio is 17.90. In terms of profitability, DBCCF's ROE is +0.13%, compared to DMPHF's ROE of +0.19%. Regarding short-term risk, DBCCF is more volatile compared to DMPHF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check DMPHF's competition here
DBCCF vs HTSUF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, HTSUF has a market cap of 2B. Regarding current trading prices, DBCCF is priced at $0.09, while HTSUF trades at $29.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas HTSUF's P/E ratio is 16.76. In terms of profitability, DBCCF's ROE is +0.13%, compared to HTSUF's ROE of +0.07%. Regarding short-term risk, DBCCF is more volatile compared to HTSUF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check HTSUF's competition here
DBCCF vs ARSUF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, ARSUF has a market cap of 2B. Regarding current trading prices, DBCCF is priced at $0.09, while ARSUF trades at $27.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas ARSUF's P/E ratio is 18.75. In terms of profitability, DBCCF's ROE is +0.13%, compared to ARSUF's ROE of +0.17%. Regarding short-term risk, DBCCF is more volatile compared to ARSUF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check ARSUF's competition here
DBCCF vs DUTV Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, DUTV has a market cap of 1.9B. Regarding current trading prices, DBCCF is priced at $0.09, while DUTV trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas DUTV's P/E ratio is N/A. In terms of profitability, DBCCF's ROE is +0.13%, compared to DUTV's ROE of -0.04%. Regarding short-term risk, DBCCF is less volatile compared to DUTV. This indicates potentially lower risk in terms of short-term price fluctuations for DBCCF.Check DUTV's competition here
DBCCF vs CURLF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, CURLF has a market cap of 1.8B. Regarding current trading prices, DBCCF is priced at $0.09, while CURLF trades at $2.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas CURLF's P/E ratio is -7.12. In terms of profitability, DBCCF's ROE is +0.13%, compared to CURLF's ROE of -0.29%. Regarding short-term risk, DBCCF is more volatile compared to CURLF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check CURLF's competition here
DBCCF vs TSMRF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, TSMRF has a market cap of 1.7B. Regarding current trading prices, DBCCF is priced at $0.09, while TSMRF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas TSMRF's P/E ratio is 10.04. In terms of profitability, DBCCF's ROE is +0.13%, compared to TSMRF's ROE of +0.10%. Regarding short-term risk, DBCCF is less volatile compared to TSMRF. This indicates potentially lower risk in terms of short-term price fluctuations for DBCCF.Check TSMRF's competition here
DBCCF vs SHPHF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, SHPHF has a market cap of 1.7B. Regarding current trading prices, DBCCF is priced at $0.09, while SHPHF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas SHPHF's P/E ratio is -6.22. In terms of profitability, DBCCF's ROE is +0.13%, compared to SHPHF's ROE of -0.02%. Regarding short-term risk, DBCCF is more volatile compared to SHPHF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check SHPHF's competition here
DBCCF vs MITPF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, DBCCF is priced at $0.09, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas MITPF's P/E ratio is -10.81. In terms of profitability, DBCCF's ROE is +0.13%, compared to MITPF's ROE of +4.99%. Regarding short-term risk, DBCCF is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for DBCCF.Check MITPF's competition here
DBCCF vs GTBIF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, GTBIF has a market cap of 1.6B. Regarding current trading prices, DBCCF is priced at $0.09, while GTBIF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas GTBIF's P/E ratio is 13.63. In terms of profitability, DBCCF's ROE is +0.13%, compared to GTBIF's ROE of +0.06%. Regarding short-term risk, DBCCF is more volatile compared to GTBIF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check GTBIF's competition here
DBCCF vs KARBF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, DBCCF is priced at $0.09, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas KARBF's P/E ratio is 262.50. In terms of profitability, DBCCF's ROE is +0.13%, compared to KARBF's ROE of N/A. Regarding short-term risk, DBCCF is more volatile compared to KARBF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check KARBF's competition here
DBCCF vs CHIZF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, CHIZF has a market cap of 1.4B. Regarding current trading prices, DBCCF is priced at $0.09, while CHIZF trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas CHIZF's P/E ratio is -27.34. In terms of profitability, DBCCF's ROE is +0.13%, compared to CHIZF's ROE of -0.01%. Regarding short-term risk, DBCCF is more volatile compared to CHIZF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check CHIZF's competition here
DBCCF vs CASBF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, CASBF has a market cap of 1.3B. Regarding current trading prices, DBCCF is priced at $0.09, while CASBF trades at $3.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas CASBF's P/E ratio is -38.60. In terms of profitability, DBCCF's ROE is +0.13%, compared to CASBF's ROE of +0.01%. Regarding short-term risk, DBCCF is more volatile compared to CASBF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check CASBF's competition here
DBCCF vs SWGHF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, SWGHF has a market cap of 1.3B. Regarding current trading prices, DBCCF is priced at $0.09, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, DBCCF's ROE is +0.13%, compared to SWGHF's ROE of +0.05%. Regarding short-term risk, DBCCF is more volatile compared to SWGHF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check SWGHF's competition here
DBCCF vs LJUIF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, LJUIF has a market cap of 1.2B. Regarding current trading prices, DBCCF is priced at $0.09, while LJUIF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas LJUIF's P/E ratio is 13.42. In terms of profitability, DBCCF's ROE is +0.13%, compared to LJUIF's ROE of +0.09%. Regarding short-term risk, DBCCF is less volatile compared to LJUIF. This indicates potentially lower risk in terms of short-term price fluctuations for DBCCF.Check LJUIF's competition here
DBCCF vs TCNNF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, TCNNF has a market cap of 1.2B. Regarding current trading prices, DBCCF is priced at $0.09, while TCNNF trades at $6.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas TCNNF's P/E ratio is -10.60. In terms of profitability, DBCCF's ROE is +0.13%, compared to TCNNF's ROE of -0.10%. Regarding short-term risk, DBCCF is more volatile compared to TCNNF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check TCNNF's competition here
DBCCF vs BIOGY Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, BIOGY has a market cap of 1.1B. Regarding current trading prices, DBCCF is priced at $0.09, while BIOGY trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas BIOGY's P/E ratio is 31.43. In terms of profitability, DBCCF's ROE is +0.13%, compared to BIOGY's ROE of +0.24%. Regarding short-term risk, DBCCF is more volatile compared to BIOGY. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check BIOGY's competition here
DBCCF vs KSPHF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, KSPHF has a market cap of 1.1B. Regarding current trading prices, DBCCF is priced at $0.09, while KSPHF trades at $25.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas KSPHF's P/E ratio is 11.99. In terms of profitability, DBCCF's ROE is +0.13%, compared to KSPHF's ROE of +0.07%. Regarding short-term risk, DBCCF is more volatile compared to KSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check KSPHF's competition here
DBCCF vs KKPCF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, KKPCF has a market cap of 984.6M. Regarding current trading prices, DBCCF is priced at $0.09, while KKPCF trades at $26.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas KKPCF's P/E ratio is 288.89. In terms of profitability, DBCCF's ROE is +0.13%, compared to KKPCF's ROE of -0.03%. Regarding short-term risk, DBCCF is more volatile compared to KKPCF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check KKPCF's competition here
DBCCF vs GNMLF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, GNMLF has a market cap of 973.8M. Regarding current trading prices, DBCCF is priced at $0.09, while GNMLF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas GNMLF's P/E ratio is 11.11. In terms of profitability, DBCCF's ROE is +0.13%, compared to GNMLF's ROE of +0.11%. Regarding short-term risk, DBCCF is more volatile compared to GNMLF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check GNMLF's competition here
DBCCF vs EVOTF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, EVOTF has a market cap of 931.2M. Regarding current trading prices, DBCCF is priced at $0.09, while EVOTF trades at $5.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas EVOTF's P/E ratio is -5.04. In terms of profitability, DBCCF's ROE is +0.13%, compared to EVOTF's ROE of -0.18%. Regarding short-term risk, DBCCF is less volatile compared to EVOTF. This indicates potentially lower risk in terms of short-term price fluctuations for DBCCF.Check EVOTF's competition here
DBCCF vs TWAPF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, TWAPF has a market cap of 828.5M. Regarding current trading prices, DBCCF is priced at $0.09, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas TWAPF's P/E ratio is 6.28. In terms of profitability, DBCCF's ROE is +0.13%, compared to TWAPF's ROE of +0.12%. Regarding short-term risk, DBCCF is less volatile compared to TWAPF. This indicates potentially lower risk in terms of short-term price fluctuations for DBCCF.Check TWAPF's competition here
DBCCF vs NIKA Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, NIKA has a market cap of 785.6M. Regarding current trading prices, DBCCF is priced at $0.09, while NIKA trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas NIKA's P/E ratio is N/A. In terms of profitability, DBCCF's ROE is +0.13%, compared to NIKA's ROE of +0.21%. Regarding short-term risk, DBCCF is more volatile compared to NIKA. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check NIKA's competition here
DBCCF vs CSWYF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, CSWYF has a market cap of 758.4M. Regarding current trading prices, DBCCF is priced at $0.09, while CSWYF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas CSWYF's P/E ratio is 4.78. In terms of profitability, DBCCF's ROE is +0.13%, compared to CSWYF's ROE of +0.20%. Regarding short-term risk, DBCCF is more volatile compared to CSWYF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check CSWYF's competition here
DBCCF vs TRXPF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, DBCCF is priced at $0.09, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, DBCCF's ROE is +0.13%, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, DBCCF is more volatile compared to TRXPF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check TRXPF's competition here
DBCCF vs SHEZF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, SHEZF has a market cap of 690.3M. Regarding current trading prices, DBCCF is priced at $0.09, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, DBCCF's ROE is +0.13%, compared to SHEZF's ROE of +0.03%. Regarding short-term risk, DBCCF is less volatile compared to SHEZF. This indicates potentially lower risk in terms of short-term price fluctuations for DBCCF.Check SHEZF's competition here
DBCCF vs YIHCF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, YIHCF has a market cap of 643.1M. Regarding current trading prices, DBCCF is priced at $0.09, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, DBCCF's ROE is +0.13%, compared to YIHCF's ROE of +0.06%. Regarding short-term risk, DBCCF is more volatile compared to YIHCF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check YIHCF's competition here
DBCCF vs GLASF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, GLASF has a market cap of 624.8M. Regarding current trading prices, DBCCF is priced at $0.09, while GLASF trades at $8.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas GLASF's P/E ratio is -38.50. In terms of profitability, DBCCF's ROE is +0.13%, compared to GLASF's ROE of -0.22%. Regarding short-term risk, DBCCF is more volatile compared to GLASF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check GLASF's competition here
DBCCF vs AIHLF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, AIHLF has a market cap of 624.3M. Regarding current trading prices, DBCCF is priced at $0.09, while AIHLF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas AIHLF's P/E ratio is 10.94. In terms of profitability, DBCCF's ROE is +0.13%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, DBCCF is more volatile compared to AIHLF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check AIHLF's competition here
DBCCF vs TRSSF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, DBCCF is priced at $0.09, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, DBCCF's ROE is +0.13%, compared to TRSSF's ROE of -0.68%. Regarding short-term risk, DBCCF is more volatile compared to TRSSF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check TRSSF's competition here
DBCCF vs PKBFF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, PKBFF has a market cap of 544.7M. Regarding current trading prices, DBCCF is priced at $0.09, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas PKBFF's P/E ratio is N/A. In terms of profitability, DBCCF's ROE is +0.13%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, DBCCF is more volatile compared to PKBFF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check PKBFF's competition here
DBCCF vs CCHWF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, DBCCF is priced at $0.09, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, DBCCF's ROE is +0.13%, compared to CCHWF's ROE of +0.42%. Regarding short-term risk, DBCCF is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for DBCCF.Check CCHWF's competition here
DBCCF vs BOIRF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, BOIRF has a market cap of 520.9M. Regarding current trading prices, DBCCF is priced at $0.09, while BOIRF trades at $30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas BOIRF's P/E ratio is 22.73. In terms of profitability, DBCCF's ROE is +0.13%, compared to BOIRF's ROE of +0.05%. Regarding short-term risk, DBCCF is more volatile compared to BOIRF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check BOIRF's competition here
DBCCF vs AGYTF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, AGYTF has a market cap of 504.6M. Regarding current trading prices, DBCCF is priced at $0.09, while AGYTF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas AGYTF's P/E ratio is -11.00. In terms of profitability, DBCCF's ROE is +0.13%, compared to AGYTF's ROE of +1.75%. Regarding short-term risk, DBCCF is more volatile compared to AGYTF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check AGYTF's competition here
DBCCF vs KHTRF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, KHTRF has a market cap of 498.1M. Regarding current trading prices, DBCCF is priced at $0.09, while KHTRF trades at $5.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas KHTRF's P/E ratio is -127.02. In terms of profitability, DBCCF's ROE is +0.13%, compared to KHTRF's ROE of -0.01%. Regarding short-term risk, DBCCF is more volatile compared to KHTRF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check KHTRF's competition here
DBCCF vs PEXXF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, DBCCF is priced at $0.09, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, DBCCF's ROE is +0.13%, compared to PEXXF's ROE of N/A. Regarding short-term risk, DBCCF is more volatile compared to PEXXF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check PEXXF's competition here
DBCCF vs SWDCF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, SWDCF has a market cap of 439.2M. Regarding current trading prices, DBCCF is priced at $0.09, while SWDCF trades at $2.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas SWDCF's P/E ratio is 68.69. In terms of profitability, DBCCF's ROE is +0.13%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, DBCCF is less volatile compared to SWDCF. This indicates potentially lower risk in terms of short-term price fluctuations for DBCCF.Check SWDCF's competition here
DBCCF vs VRNOF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, VRNOF has a market cap of 434.2M. Regarding current trading prices, DBCCF is priced at $0.09, while VRNOF trades at $1.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas VRNOF's P/E ratio is -1.21. In terms of profitability, DBCCF's ROE is +0.13%, compared to VRNOF's ROE of -0.30%. Regarding short-term risk, DBCCF is more volatile compared to VRNOF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check VRNOF's competition here
DBCCF vs ELTP Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, ELTP has a market cap of 420M. Regarding current trading prices, DBCCF is priced at $0.09, while ELTP trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas ELTP's P/E ratio is 9.75. In terms of profitability, DBCCF's ROE is +0.13%, compared to ELTP's ROE of +0.71%. Regarding short-term risk, DBCCF is more volatile compared to ELTP. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check ELTP's competition here
DBCCF vs HUMDF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, HUMDF has a market cap of 407.7M. Regarding current trading prices, DBCCF is priced at $0.09, while HUMDF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas HUMDF's P/E ratio is 2.58. In terms of profitability, DBCCF's ROE is +0.13%, compared to HUMDF's ROE of +2.33%. Regarding short-term risk, DBCCF is more volatile compared to HUMDF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check HUMDF's competition here
DBCCF vs CRLBF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, CRLBF has a market cap of 330.9M. Regarding current trading prices, DBCCF is priced at $0.09, while CRLBF trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas CRLBF's P/E ratio is -2.54. In terms of profitability, DBCCF's ROE is +0.13%, compared to CRLBF's ROE of -0.33%. Regarding short-term risk, DBCCF is more volatile compared to CRLBF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check CRLBF's competition here
DBCCF vs CPHRF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, CPHRF has a market cap of 309M. Regarding current trading prices, DBCCF is priced at $0.09, while CPHRF trades at $12.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas CPHRF's P/E ratio is 11.60. In terms of profitability, DBCCF's ROE is +0.13%, compared to CPHRF's ROE of +0.24%. Regarding short-term risk, DBCCF is more volatile compared to CPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check CPHRF's competition here
DBCCF vs PROCF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, PROCF has a market cap of 253.4M. Regarding current trading prices, DBCCF is priced at $0.09, while PROCF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas PROCF's P/E ratio is 0.27. In terms of profitability, DBCCF's ROE is +0.13%, compared to PROCF's ROE of -2.24%. Regarding short-term risk, DBCCF is less volatile compared to PROCF. This indicates potentially lower risk in terms of short-term price fluctuations for DBCCF.Check PROCF's competition here
DBCCF vs BHCCF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, BHCCF has a market cap of 225.1M. Regarding current trading prices, DBCCF is priced at $0.09, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, DBCCF's ROE is +0.13%, compared to BHCCF's ROE of +0.23%. Regarding short-term risk, DBCCF is more volatile compared to BHCCF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check BHCCF's competition here
DBCCF vs PLNHF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, DBCCF is priced at $0.09, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, DBCCF's ROE is +0.13%, compared to PLNHF's ROE of -0.94%. Regarding short-term risk, DBCCF is more volatile compared to PLNHF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check PLNHF's competition here
DBCCF vs PHCUF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, PHCUF has a market cap of 188.1M. Regarding current trading prices, DBCCF is priced at $0.09, while PHCUF trades at $7.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas PHCUF's P/E ratio is -707.00. In terms of profitability, DBCCF's ROE is +0.13%, compared to PHCUF's ROE of -0.00%. Regarding short-term risk, DBCCF is more volatile compared to PHCUF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check PHCUF's competition here
DBCCF vs SHIEF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, SHIEF has a market cap of 150.9M. Regarding current trading prices, DBCCF is priced at $0.09, while SHIEF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas SHIEF's P/E ratio is -7.06. In terms of profitability, DBCCF's ROE is +0.13%, compared to SHIEF's ROE of +1.40%. Regarding short-term risk, DBCCF is more volatile compared to SHIEF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check SHIEF's competition here
DBCCF vs CBWTF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, CBWTF has a market cap of 134.8M. Regarding current trading prices, DBCCF is priced at $0.09, while CBWTF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas CBWTF's P/E ratio is 3.33. In terms of profitability, DBCCF's ROE is +0.13%, compared to CBWTF's ROE of +0.29%. Regarding short-term risk, DBCCF is more volatile compared to CBWTF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check CBWTF's competition here
DBCCF vs COPHF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, DBCCF is priced at $0.09, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas COPHF's P/E ratio is -0.02. In terms of profitability, DBCCF's ROE is +0.13%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, DBCCF is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for DBCCF.Check COPHF's competition here
DBCCF vs LOVFF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, LOVFF has a market cap of 124.5M. Regarding current trading prices, DBCCF is priced at $0.09, while LOVFF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas LOVFF's P/E ratio is 14.44. In terms of profitability, DBCCF's ROE is +0.13%, compared to LOVFF's ROE of +0.12%. Regarding short-term risk, DBCCF is more volatile compared to LOVFF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check LOVFF's competition here
DBCCF vs NWPN Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, DBCCF is priced at $0.09, while NWPN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas NWPN's P/E ratio is -0.04. In terms of profitability, DBCCF's ROE is +0.13%, compared to NWPN's ROE of +0.13%. Regarding short-term risk, DBCCF is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for DBCCF.Check NWPN's competition here
DBCCF vs BIOYF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, BIOYF has a market cap of 121.9M. Regarding current trading prices, DBCCF is priced at $0.09, while BIOYF trades at $10.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas BIOYF's P/E ratio is 18.28. In terms of profitability, DBCCF's ROE is +0.13%, compared to BIOYF's ROE of +0.23%. Regarding short-term risk, DBCCF is more volatile compared to BIOYF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check BIOYF's competition here
DBCCF vs CWBHF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, CWBHF has a market cap of 118M. Regarding current trading prices, DBCCF is priced at $0.09, while CWBHF trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas CWBHF's P/E ratio is -5.29. In terms of profitability, DBCCF's ROE is +0.13%, compared to CWBHF's ROE of -1.20%. Regarding short-term risk, DBCCF is more volatile compared to CWBHF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check CWBHF's competition here
DBCCF vs LPCUF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, LPCUF has a market cap of 112.1M. Regarding current trading prices, DBCCF is priced at $0.09, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas LPCUF's P/E ratio is 9.51. In terms of profitability, DBCCF's ROE is +0.13%, compared to LPCUF's ROE of +0.04%. Regarding short-term risk, DBCCF is more volatile compared to LPCUF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check LPCUF's competition here
DBCCF vs CNVCF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, DBCCF is priced at $0.09, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, DBCCF's ROE is +0.13%, compared to CNVCF's ROE of +1.21%. Regarding short-term risk, DBCCF is more volatile compared to CNVCF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check CNVCF's competition here
DBCCF vs ORXOY Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, ORXOY has a market cap of 97.2M. Regarding current trading prices, DBCCF is priced at $0.09, while ORXOY trades at $2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas ORXOY's P/E ratio is -2.26. In terms of profitability, DBCCF's ROE is +0.13%, compared to ORXOY's ROE of +5.65%. Regarding short-term risk, DBCCF is more volatile compared to ORXOY. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check ORXOY's competition here
DBCCF vs ABSCF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, ABSCF has a market cap of 96M. Regarding current trading prices, DBCCF is priced at $0.09, while ABSCF trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas ABSCF's P/E ratio is -8.53. In terms of profitability, DBCCF's ROE is +0.13%, compared to ABSCF's ROE of +0.33%. Regarding short-term risk, DBCCF is less volatile compared to ABSCF. This indicates potentially lower risk in terms of short-term price fluctuations for DBCCF.Check ABSCF's competition here
DBCCF vs AAWH Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, AAWH has a market cap of 95M. Regarding current trading prices, DBCCF is priced at $0.09, while AAWH trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas AAWH's P/E ratio is -0.81. In terms of profitability, DBCCF's ROE is +0.13%, compared to AAWH's ROE of -14.10%. Regarding short-term risk, DBCCF is more volatile compared to AAWH. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check AAWH's competition here
DBCCF vs HLTRF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, HLTRF has a market cap of 93.8M. Regarding current trading prices, DBCCF is priced at $0.09, while HLTRF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas HLTRF's P/E ratio is -7.69. In terms of profitability, DBCCF's ROE is +0.13%, compared to HLTRF's ROE of -0.19%. Regarding short-term risk, DBCCF is more volatile compared to HLTRF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check HLTRF's competition here
DBCCF vs JUSHF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, JUSHF has a market cap of 88.7M. Regarding current trading prices, DBCCF is priced at $0.09, while JUSHF trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas JUSHF's P/E ratio is -1.37. In terms of profitability, DBCCF's ROE is +0.13%, compared to JUSHF's ROE of +0.89%. Regarding short-term risk, DBCCF is more volatile compared to JUSHF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check JUSHF's competition here
DBCCF vs ORXOF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, ORXOF has a market cap of 79.3M. Regarding current trading prices, DBCCF is priced at $0.09, while ORXOF trades at $2.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas ORXOF's P/E ratio is -1.84. In terms of profitability, DBCCF's ROE is +0.13%, compared to ORXOF's ROE of +5.65%. Regarding short-term risk, DBCCF is less volatile compared to ORXOF. This indicates potentially lower risk in terms of short-term price fluctuations for DBCCF.Check ORXOF's competition here
DBCCF vs GRUSF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, GRUSF has a market cap of 77.4M. Regarding current trading prices, DBCCF is priced at $0.09, while GRUSF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas GRUSF's P/E ratio is 10.33. In terms of profitability, DBCCF's ROE is +0.13%, compared to GRUSF's ROE of +0.28%. Regarding short-term risk, DBCCF is more volatile compared to GRUSF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check GRUSF's competition here
DBCCF vs EOFBY Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, EOFBY has a market cap of 73.7M. Regarding current trading prices, DBCCF is priced at $0.09, while EOFBY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, DBCCF's ROE is +0.13%, compared to EOFBY's ROE of -0.77%. Regarding short-term risk, DBCCF is more volatile compared to EOFBY. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check EOFBY's competition here
DBCCF vs MEDXF Comparison March 2026
DBCCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DBCCF stands at 52.2M. In comparison, MEDXF has a market cap of 73.6M. Regarding current trading prices, DBCCF is priced at $0.09, while MEDXF trades at $2.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DBCCF currently has a P/E ratio of 4.53, whereas MEDXF's P/E ratio is -114.00. In terms of profitability, DBCCF's ROE is +0.13%, compared to MEDXF's ROE of -0.01%. Regarding short-term risk, DBCCF is more volatile compared to MEDXF. This indicates potentially higher risk in terms of short-term price fluctuations for DBCCF.Check MEDXF's competition here